Rabeprazole- and vonoprazan-based dual therapies for H pylori eradication: effective with low side effects, rabeprazole being more cost-effective
Dual therapy based on rabeprazole or vonoprazan effectively improves symptoms in patients with Hp infection, with relatively few adverse reactions and good treatment compliance. Additionally, rabeprazole-based dual therapy had a lower cost.
Authors
- Xiaoran Sun (ORCID: https://orcid.org/0000-0002-5892-4471)
Institutions
- Hebei North University (CN)
Publication Details
- Journal
- American Journal of Translational Research
- Published
- 2025-01-01
- DOI
- https://doi.org/10.62347/ewfj6972
- Citations
- 1
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 2.01